Immuno Oncology Talks

Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy

November 09, 2022 Sanofi Season 1 Episode 3
Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy
Immuno Oncology Talks
More Info
Immuno Oncology Talks
Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy
Nov 09, 2022 Season 1 Episode 3
Sanofi

In the third episode of the “Immuno Oncology Talks”, we have had the pleasure to discuss tumor infiltrating lymphocytes for adoptive cell therapy with Professor Inge Marie Svane from the National Center for Cancer Immune Therapy in Denmark. Professor Inge Marie Svane has built up this centre into a leading European translational research centre. Apart from her vast expertise is T-cell based adoptive cell therapy, her research also focuses on other cellular therapies, cancer vaccines, and immune regulation.

MAT-BE-2200834 (ver. 1.0) 11 2022

Show Notes

In the third episode of the “Immuno Oncology Talks”, we have had the pleasure to discuss tumor infiltrating lymphocytes for adoptive cell therapy with Professor Inge Marie Svane from the National Center for Cancer Immune Therapy in Denmark. Professor Inge Marie Svane has built up this centre into a leading European translational research centre. Apart from her vast expertise is T-cell based adoptive cell therapy, her research also focuses on other cellular therapies, cancer vaccines, and immune regulation.

MAT-BE-2200834 (ver. 1.0) 11 2022